Calavo Growers Reports Significant Q1 Earnings Miss Amidst Merger Progress
summarizeSummary
Calavo Growers announced disappointing first-quarter 2026 financial results, with significant declines in sales and net income, partially due to M&A-related expenses, while also confirming progress on its merger with Mission Produce.
check_boxKey Events
-
Significant Revenue Decline
Total net sales decreased by 20.8% to $122.2 million in the first fiscal quarter of 2026, down from $154.4 million in the prior year period.
-
Sharp Profitability Drop
GAAP net income attributable to Calavo Growers, Inc. fell 84.1% to $0.7 million, and adjusted diluted EPS decreased 22.9% to $0.27 per share.
-
M&A-Related Expenses Impact
Selling, general, and administrative (SG&A) expenses rose significantly to $16.4 million, including $7.2 million in non-recurring costs, primarily $4.9 million for the Mission Produce merger.
-
Merger Progress Confirmed
The company confirmed progress on its merger with Mission Produce, including initial antitrust submissions, and reiterated the expected closing in the third fiscal quarter of 2026, with no material changes to the merger agreement terms.
auto_awesomeAnalysis
Calavo Growers reported a substantial decline in its first-quarter financial performance, with net sales dropping over 20% and GAAP net income plummeting by more than 80% year-over-year. This significant underperformance indicates challenges in its core fresh avocado and tomato businesses, despite volume increases in avocados. The company's profitability was further impacted by substantial non-recurring expenses related to its ongoing merger with Mission Produce. While management noted progress on the merger, the immediate focus for investors will likely be on the sharp deterioration in earnings and the outlook for continued pricing pressure in the fresh avocado market.
At the time of this filing, CVGW was trading at $24.99 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $446.7M. The 52-week trading range was $18.40 to $28.72. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.